The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine).
Bartosik-Psujek
H
H
Katedra i Klinika Neurologii Akademii Medycznej w Lublinie.
Stelmasiak
Z
Z
Mitosek-Szewczyk
K
K
Belniak-Legieć
E
E
Dobosz
B
B
D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology*; D017338:Cladribine / Q000494:pharmacology*; D003176:Complement C3 / Q000032:analysis*; D003181:Complement C4 / Q000032:analysis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology*
D003176:Complement C3; D003181:Complement C4; D017338:Cladribine